Monges Viviane
Director
- Shares
- 11,969
- Price
- $33.05
- Value
- $395,524
PHVS
10 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$20,414,903
0 buyers · 10 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$33,020,991
11 distinct insiders
Highlighted alerts
18
53 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
PHVS overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
Represents shares withheld by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock units.
Voluntary purchases and sales; administrative noise stays hidden.
Monges Viviane
Director
Schikan Johannes Gerardus Christiaan Petrus
Director
Nassif David W.
CFO / CLO
Lu Peng
President
Schikan Johannes Gerardus Christiaan Petrus
Director
Bjork Elisabeth
Director
Glassman Robert
Director
Lesage Anne
Chief Early Development
Abele Stefan Andreas
Chief Technical Ops Officer
Abele Stefan Andreas
Chief Technical Ops Officer
Glassman Robert
Director
Souverijns Wim
Chief Commercial Officer
Souverijns Wim
Chief Commercial Officer
Modig Berndt
Chief Executive Officer
Lu Peng
President
Lesage Anne
Chief Early Development
Glassman Robert
Director
Lu Peng
President
Modig Berndt
Chief Executive Officer
Modig Berndt
Chief Executive Officer
Schikan Johannes Gerardus Christiaan Petrus
Director
Lesage Anne
Chief Early Development
Lesage Anne
Chief Early Development
Schikan Johannes Gerardus Christiaan Petrus
Director
Lesage Anne
Chief Early Development
Lesage Anne
Chief Early Development
Lesage Anne
Chief Early Development
Schikan Johannes Gerardus Christiaan Petrus
Director
Lu Peng
Chief Medical Officer
Lesage Anne
Chief Early Development
Lesage Anne
Chief Early Development
Lu Peng
Chief Medical Officer
Lu Peng
Chief Medical Officer
Lu Peng
Chief Medical Officer
Modig Berndt
Chief Executive Officer
Modig Berndt
Chief Executive Officer
Nijdam Anna
Principal Accounting Officer
Nijdam Anna
Principal Accounting Officer
Monges Viviane
Director
Nijdam Anna
Principal Accounting Officer
Nassif David W.
CFO / CLO
Bjork Elisabeth
Director
Modig Berndt
Chief Executive Officer
Glassman Robert
Director
Glassman Robert
Director
Abele Stefan Andreas
Chief Technical Ops Officer
Souverijns Wim
Chief Commercial Officer
Lu Peng
Chief Medical Officer
Lu Peng
Chief Medical Officer
Schikan Johannes Gerardus Christiaan Petrus
Director
Schikan Johannes Gerardus Christiaan Petrus
Director
Lesage Anne
Chief Early Development
Lesage Anne
Chief Early Development
Lesage Anne
Chief Early Development
Lu Peng
Chief Medical Officer
Schikan Johannes Gerardus Christiaan Petrus
Director
Lesage Anne
Chief Early Development
Lesage Anne
Chief Early Development
Lu Peng
Chief Medical Officer
Schikan Johannes Gerardus Christiaan Petrus
Director
Lesage Anne
Chief Early Development
Lesage Anne
Chief Early Development
Lu Peng
Chief Medical Officer
Schikan Johannes Gerardus Christiaan Petrus
Director
Lesage Anne
Chief Early Development
Lesage Anne
Chief Early Development
Lesage Anne
Chief Early Development
Lu Peng
Chief Medical Officer
Modig Berndt
Chief Executive Officer
Modig Berndt
Chief Executive Officer
Modig Berndt
Chief Executive Officer
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 23, 2026 | Monges Viviane Director | Sale | 11,969 | $33.05 | $395,524 | |
| Sep 22, 2026 | Schikan Johannes Gerardus Christiaan Petrus Director | Sale | 800 | $36.19 | $28,952 | |
| Sep 21, 2026 | Nassif David W. CFO / CLO | Sale | 6,000 | $36.47 | $218,801 | |
| Sep 17, 2026 | Lu Peng President | Sale | 100,000 | $35.00 | $3,500,000 | |
| Sep 17, 2026 | Schikan Johannes Gerardus Christiaan Petrus Director | Sale | 200,000 | $35.00 | $7,000,000 | |
| Sep 17, 2026 | Bjork Elisabeth Director | Sale | 52,500 | $37.89 | $1,989,409 | |
| Sep 17, 2026 | Glassman Robert Director | Sale | 14,493 | $38.56 | $558,812 | |
| Sep 17, 2026 | Lesage Anne Chief Early Development | Sale | 20,000 | $38.27 | $765,466 | |
| Sep 15, 2026 | Abele Stefan Andreas Chief Technical Ops Officer | Sale | 1,400 | $39.24 | $54,938 | |
| Sep 15, 2026 | Abele Stefan Andreas Chief Technical Ops Officer | Sale | 45,000 | $38.14 | $1,716,188 | |
| Sep 15, 2026 | Glassman Robert Director | Sale | 8,667 | $38.27 | $331,716 | |
| Sep 15, 2026 | Souverijns Wim Chief Commercial Officer | Sale | 6,090 | $38.99 | $237,449 | |
| Sep 14, 2026 | Souverijns Wim Chief Commercial Officer | Sale | 20,000 | $39.31 | $786,126 | |
| Sep 14, 2026 | Modig Berndt Chief Executive Officer | Sale | 2,291 | $39.40 | $90,276 | |
| Sep 11, 2026 | Lu Peng President | Sale | 15,000 | $40.13 | $601,947 | |
| Sep 10, 2026 | Lesage Anne Chief Early Development | Sale | 30,000 | $38.30 | $1,149,084 | |
| Sep 09, 2026 | Glassman Robert Director | Sale | 8,000 | $37.55 | $300,396 | |
| Sep 08, 2026 | Lu Peng President | Sale | 15,000 | $40.68 | $610,134 | |
| Aug 14, 2026 | Modig Berndt Chief Executive Officer | Sale | 2,292 | $34.77 | $79,686 | |
| Jul 13, 2026 | Modig Berndt Chief Executive Officer | Sale | 2,292 | $34.97 | $80,154 | |
| Jun 30, 2026 | Schikan Johannes Gerardus Christiaan Petrus Director | Sale | 30,712 | $35.49 | $1,090,049 | |
| Jun 30, 2026 | Lesage Anne Chief Early Development | Sale | 27,872 | $35.48 | $988,890 | |
| Jun 30, 2026 | Lesage Anne Chief Early Development | Sale | 30,703 | $35.49 | $1,089,637 | |
| Jun 29, 2026 | Schikan Johannes Gerardus Christiaan Petrus Director | Sale | 6,888 | $35.05 | $241,447 | |
| Jun 29, 2026 | Lesage Anne Chief Early Development | Sale | 6,997 | $35.05 | $245,232 | |
| Jun 29, 2026 | Lesage Anne Chief Early Development | Sale | 8,300 | $35.05 | $290,908 | |
| Jun 29, 2026 | Lesage Anne Chief Early Development | Sale | 2,300 | $35.12 | $80,786 | |
| Jun 29, 2026 | Schikan Johannes Gerardus Christiaan Petrus Director | Sale | 2,400 | $35.10 | $84,250 | |
| Jun 26, 2026 | Lu Peng Chief Medical Officer | Sale | 14,700 | $34.00 | $499,847 | |
| Jun 25, 2026 | Lesage Anne Chief Early Development | Sale | 2,300 | $35.12 | $80,786 | |
| Jun 25, 2026 | Lesage Anne Chief Early Development | Sale | 2,300 | $35.12 | $80,775 | |
| Jun 25, 2026 | Lu Peng Chief Medical Officer | Sale | 3,400 | $35.09 | $119,310 | |
| Jun 25, 2026 | Lu Peng Chief Medical Officer | Sale | 11,600 | $34.45 | $399,675 | |
| Jun 18, 2026 | Lu Peng Chief Medical Officer | Sale | 300 | $34.00 | $10,200 | |
| Jun 15, 2026 | Modig Berndt Chief Executive Officer | Sale | 100 | $31.46 | $3,146 | |
| Jun 15, 2026 | Modig Berndt Chief Executive Officer | Sale | 2,191 | $31.05 | $68,027 | |
| Jun 04, 2026 | Nijdam Anna Principal Accounting Officer | Sale | 2,670 | $30.87 | $82,425 | |
| May 22, 2026 | Nijdam Anna Principal Accounting Officer | Sale | 5,501 | $30.74 | $169,084 | |
| May 21, 2026 | Monges Viviane Director | Sale | 9,667 | $30.29 | $292,853 | |
| May 21, 2026 | Nijdam Anna Principal Accounting Officer | Sale | 1,829 | $30.60 | $55,971 | |
| May 21, 2026 | Nassif David W. CFO / CLO | Sale | 10,000 | $30.31 | $303,076 | |
| May 20, 2026 | Bjork Elisabeth Director | Sale | 10,000 | $29.32 | $293,166 | |
| May 18, 2026 | Modig Berndt Chief Executive Officer | Sale | 2,292 | $29.22 | $66,977 | |
| May 15, 2026 | Glassman Robert Director | Sale | 4,667 | $29.82 | $139,155 | |
| May 15, 2026 | Glassman Robert Director | Sale | 5,333 | $29.83 | $159,091 | |
| May 15, 2026 | Abele Stefan Andreas Chief Technical Ops Officer | Sale | 8,748 | $29.82 | $260,864 | |
| May 15, 2026 | Souverijns Wim Chief Commercial Officer | Sale | 10,000 | $29.92 | $299,163 | |
| May 01, 2026 | Lu Peng Chief Medical Officer | Sale | 143 | $31.00 | $4,433 | |
| May 01, 2026 | Lu Peng Chief Medical Officer | Sale | 14,023 | $30.16 | $422,986 | |
| Apr 30, 2026 | Schikan Johannes Gerardus Christiaan Petrus Director | Sale | 670 | $31.03 | $20,792 | |
| Apr 30, 2026 | Schikan Johannes Gerardus Christiaan Petrus Director | Sale | 28,400 | $30.30 | $860,588 | |
| Apr 30, 2026 | Lesage Anne Chief Early Development | Sale | 19,200 | $30.26 | $580,909 | |
| Apr 30, 2026 | Lesage Anne Chief Early Development | Sale | 18,000 | $30.26 | $544,604 | |
| Apr 30, 2026 | Lesage Anne Chief Early Development | Sale | 3,700 | $30.26 | $111,946 | |
| Apr 30, 2026 | Lu Peng Chief Medical Officer | Sale | 15,000 | $30.24 | $453,627 | |
| Apr 29, 2026 | Schikan Johannes Gerardus Christiaan Petrus Director | Sale | 3,830 | $30.07 | $115,165 | |
| Apr 29, 2026 | Lesage Anne Chief Early Development | Sale | 3,700 | $30.06 | $111,229 | |
| Apr 29, 2026 | Lesage Anne Chief Early Development | Sale | 3,700 | $30.08 | $111,280 | |
| Apr 29, 2026 | Lu Peng Chief Medical Officer | Sale | 3,733 | $30.06 | $112,232 | |
| Apr 23, 2026 | Schikan Johannes Gerardus Christiaan Petrus Director | Sale | 100 | $30.03 | $3,003 | |
| Apr 23, 2026 | Lesage Anne Chief Early Development | Sale | 100 | $30.03 | $3,003 | |
| Apr 23, 2026 | Lesage Anne Chief Early Development | Sale | 100 | $30.03 | $3,003 | |
| Apr 23, 2026 | Lu Peng Chief Medical Officer | Sale | 100 | $30.03 | $3,003 | |
| Apr 22, 2026 | Schikan Johannes Gerardus Christiaan Petrus Director | Sale | 7,000 | $30.05 | $210,379 | |
| Apr 22, 2026 | Lesage Anne Chief Early Development | Sale | 7,000 | $30.05 | $210,358 | |
| Apr 22, 2026 | Lesage Anne Chief Early Development | Sale | 7,000 | $30.05 | $210,362 | |
| Apr 22, 2026 | Lesage Anne Chief Early Development | Sale | 500 | $30.00 | $15,000 | |
| Apr 22, 2026 | Lu Peng Chief Medical Officer | Sale | 7,001 | $30.05 | $210,402 | |
| Apr 16, 2026 | Modig Berndt Chief Executive Officer | Sale | 2,292 | $28.60 | $65,559 | |
| Apr 09, 2026 | Modig Berndt Chief Executive Officer | Sale | 200 | $28.42 | $5,683 | |
| Apr 09, 2026 | Modig Berndt Chief Executive Officer | Sale | 23,133 | $27.74 | $641,598 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.